Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program
Abstract
Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment.
Full citation:
Eckhardt BJ, Scherer M, Winkelstein E, Marks K, Edlin BR (2018). Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program
Open Forum Infectious Diseases, 5 (4), ofy048. doi: 10.1093/ofid/ofy048. PMCID: PMC5887278.